These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

578 related items for PubMed ID: 26498276

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. JC Virus-DNA Detection Is Associated with CD8 Effector Accumulation in Peripheral Blood of Patients with Multiple Sclerosis under Natalizumab Treatment, Independently from JC Virus Serostatus.
    Zingaropoli MA, Iannetta M, Pontecorvo S, Anzivino E, Prezioso C, Rodio DM, Morreale M, D'Abramo A, Oliva A, Lichtner M, Cortese A, Frontoni M, Pietropaolo V, Francia A, Mastroianni CM, Vullo V, Ciardi MR.
    Biomed Res Int; 2018; 2018():5297980. PubMed ID: 29682547
    [Abstract] [Full Text] [Related]

  • 6. Absence of JC polyomavirus in stool samples of patients with multiple sclerosis despite high anti-JCV antibodies in serum.
    Schweitzer F, Ladwig A, Opala S, Laurent S, Schroeter M, Goelz S, Fink GR, Wieland U, Silling S, Warnke C.
    Mult Scler Relat Disord; 2024 Jul; 87():105664. PubMed ID: 38735204
    [Abstract] [Full Text] [Related]

  • 7. Anti-JCV serology during natalizumab treatment: Review and meta-analysis of 17 independent patient cohorts analyzing anti-John Cunningham polyoma virus sero-conversion rates under natalizumab treatment and differences between technical and biological sero-converters.
    Schwab N, Schneider-Hohendorf T, Hoyt T, Gross CC, Meuth SG, Klotz L, Foley JF, Wiendl H.
    Mult Scler; 2018 Apr; 24(5):563-573. PubMed ID: 28847222
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Association of B-cell activating factor gene variants with serum anti-JCV antibody positivity in male patients with multiple sclerosis under natalizumab treatment: Implications for progressive multifocal leukoencephalopathy risk stratification.
    Skarlis C, Papadopoulos V, Raftopoulou S, Mavragani CP, Evangelopoulos ME.
    J Neurol Sci; 2024 Jun 15; 461():123046. PubMed ID: 38761670
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Natalizumab-treated patients at high risk for PML persistently excrete JC polyomavirus.
    Werner MH, Huang D.
    J Neurovirol; 2016 Dec 15; 22(6):871-875. PubMed ID: 27198748
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Assessment of JC virus DNA in blood and urine from natalizumab-treated patients.
    Rudick RA, O'Connor PW, Polman CH, Goodman AD, Ray SS, Griffith NM, Jurgensen SA, Gorelik L, Forrestal F, Sandrock AW, Goelz SE.
    Ann Neurol; 2010 Sep 15; 68(3):304-10. PubMed ID: 20737514
    [Abstract] [Full Text] [Related]

  • 17. JC virus urinary excretion and seroprevalence in natalizumab-treated multiple sclerosis patients.
    Delbue S, Elia F, Carloni C, Pecchenini V, Franciotta D, Gastaldi M, Colombo E, Signorini L, Carluccio S, Bellizzi A, Bergamaschi R, Ferrante P.
    J Neurovirol; 2015 Dec 15; 21(6):645-52. PubMed ID: 25052191
    [Abstract] [Full Text] [Related]

  • 18. Smoking is not associated with higher prevalence of JC virus in MS patients.
    Auer M, Bsteh G, Hegen H, Di Pauli F, Wurth S, Berger T, Deisenhammer F.
    Eur J Clin Microbiol Infect Dis; 2018 May 15; 37(5):907-910. PubMed ID: 29423619
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Successful pregnancy after natalizumab-associated progressive multifocal leukoencephalopathy in a patient with multiple sclerosis.
    Pitarokoili K, Hellwig K, Lukas C, Gold R.
    Mult Scler; 2017 Mar 15; 23(3):483-486. PubMed ID: 28260421
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.